nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—PTGS2—Triamcinolone—psoriasis	0.173	0.424	CbGbCtD
Tetrahydrobiopterin—PTGS2—Betamethasone—psoriasis	0.149	0.364	CbGbCtD
Tetrahydrobiopterin—PTGS2—Dexamethasone—psoriasis	0.0866	0.212	CbGbCtD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IVL—psoriasis	0.00989	0.054	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—ACE Inhibitor Pathway—REN—psoriasis	0.00944	0.0515	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—IL23A—psoriasis	0.00745	0.0406	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Effects of Nitric Oxide—NOS2—psoriasis	0.00623	0.034	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—ACE Inhibitor Pathway—ACE—psoriasis	0.00589	0.0321	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—endothelium—psoriasis	0.00536	0.257	CbGeAlD
Tetrahydrobiopterin—TPH1—Tryptophan metabolism—CAT—psoriasis	0.00533	0.0291	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—skeletal joint—psoriasis	0.0048	0.23	CbGeAlD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—IVL—psoriasis	0.00477	0.026	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.00384	0.0209	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—synovial membrane of synovial joint—psoriasis	0.00365	0.175	CbGeAlD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—IL13—psoriasis	0.00303	0.0165	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.00281	0.0153	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Nitric oxide stimulates guanylate cyclase—NOS2—psoriasis	0.00259	0.0141	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—REL—psoriasis	0.00237	0.0129	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—skin epidermis—psoriasis	0.00234	0.112	CbGeAlD
Tetrahydrobiopterin—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	0.0023	0.157	CbGdCrCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—IL13—psoriasis	0.00222	0.0121	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.0022	0.012	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—IL10—psoriasis	0.00207	0.0113	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—IL4—psoriasis	0.00201	0.011	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS2—psoriasis	0.00196	0.0107	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—IL10—psoriasis	0.0019	0.0103	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—SERPINB8—psoriasis	0.00189	0.0103	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Fluocinonide—Beclomethasone—psoriasis	0.00184	0.126	CbGdCrCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—HLA-A—psoriasis	0.00182	0.00994	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—NOS2—psoriasis	0.00182	0.00991	CbGpPWpGaD
Tetrahydrobiopterin—TH—Dopaminergic Neurogenesis—STAT3—psoriasis	0.00179	0.00977	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.00179	0.122	CbGdCrCtD
Tetrahydrobiopterin—NOS3—tendon—psoriasis	0.00174	0.0835	CbGeAlD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—IL13—psoriasis	0.00174	0.00949	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—endothelium—psoriasis	0.0017	0.0814	CbGeAlD
Tetrahydrobiopterin—NOS3—Angiogenesis—VEGFA—psoriasis	0.0015	0.00817	CbGpPWpGaD
Tetrahydrobiopterin—TH—Monoamine Transport—TNF—psoriasis	0.00147	0.00803	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	0.00146	0.00798	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Overview of nanoparticle effects—CRP—psoriasis	0.0014	0.00763	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—IFNG—psoriasis	0.00139	0.0076	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.00139	0.0948	CbGdCrCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—IL10—psoriasis	0.00139	0.00756	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Thromboxane A2 receptor signaling—ICAM1—psoriasis	0.00132	0.00722	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—psoriasis	0.0013	0.00712	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—CXCL8—psoriasis	0.0013	0.00707	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFR1 specific signals—VEGFA—psoriasis	0.00129	0.00702	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—LEP—psoriasis	0.00127	0.00695	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—NDUFA5—psoriasis	0.00124	0.00678	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—IFNG—psoriasis	0.00122	0.00663	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—JUN—psoriasis	0.00121	0.00662	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—JUN—psoriasis	0.0012	0.00657	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—NOS2—psoriasis	0.00119	0.00647	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—psoriasis	0.00115	0.00629	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—NOS2—psoriasis	0.00115	0.00628	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—NFKBIA—psoriasis	0.00115	0.00628	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—CXCL8—psoriasis	0.00113	0.00617	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—LEP—psoriasis	0.00112	0.00609	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	0.00111	0.076	CbGdCrCtD
Tetrahydrobiopterin—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	0.00111	0.076	CbGdCrCtD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—PPARG—psoriasis	0.00111	0.00605	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—IL10—psoriasis	0.00109	0.00594	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.00108	0.0738	CbGdCrCtD
Tetrahydrobiopterin—TPH1—Metabolism—CYP2S1—psoriasis	0.00106	0.00577	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—JUN—psoriasis	0.00105	0.00573	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.00104	0.00565	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Platelet homeostasis—NOS2—psoriasis	0.00101	0.0055	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—IFNG—psoriasis	0.000979	0.00534	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.00097	0.00529	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—JUN—psoriasis	0.000964	0.00526	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000934	0.00509	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000928	0.00506	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—NFKB1—psoriasis	0.000918	0.00501	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Overview of nanoparticle effects—CXCL8—psoriasis	0.000909	0.00496	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—NDUFA5—psoriasis	0.000909	0.00496	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—NFKBIA—psoriasis	0.000883	0.00482	CbGpPWpGaD
Tetrahydrobiopterin—Agitation—Mycophenolic acid—psoriasis	0.000862	0.00232	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Acitretin—psoriasis	0.000858	0.0023	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000855	0.0023	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Hydrocortisone—psoriasis	0.000851	0.00228	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.000847	0.00462	CbGpPWpGaD
Tetrahydrobiopterin—Upper respiratory tract infection—Triamcinolone—psoriasis	0.000847	0.00227	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Hydrocortisone—psoriasis	0.000846	0.00227	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Mycophenolate mofetil—psoriasis	0.000844	0.00227	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.000842	0.00459	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Fluocinonide—Dexamethasone—psoriasis	0.00084	0.0574	CbGdCrCtD
Tetrahydrobiopterin—PTGS2—Fluocinonide—Betamethasone—psoriasis	0.00084	0.0574	CbGdCrCtD
Tetrahydrobiopterin—Oedema peripheral—Mycophenolate mofetil—psoriasis	0.000838	0.00225	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Prednisone—psoriasis	0.000833	0.00224	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Calcitriol—psoriasis	0.000832	0.00223	CcSEcCtD
Tetrahydrobiopterin—Rash—Calcitriol—psoriasis	0.000825	0.00222	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Calcitriol—psoriasis	0.000824	0.00221	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Fluocinonide—Triamcinolone—psoriasis	0.00082	0.0561	CbGdCrCtD
Tetrahydrobiopterin—Headache—Calcitriol—psoriasis	0.00082	0.0022	CcSEcCtD
Tetrahydrobiopterin—Cough—Mycophenolic acid—psoriasis	0.000819	0.0022	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Mycophenolic acid—psoriasis	0.000813	0.00218	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Hydroxyurea—psoriasis	0.000805	0.00216	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Triamcinolone—psoriasis	0.000801	0.00215	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Mycophenolic acid—psoriasis	0.000799	0.00214	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Acitretin—psoriasis	0.000797	0.00214	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Triamcinolone—psoriasis	0.000797	0.00214	CcSEcCtD
Tetrahydrobiopterin—Irritability—Prednisone—psoriasis	0.000795	0.00214	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000794	0.00213	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.000793	0.00213	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Methotrexate—psoriasis	0.000793	0.00213	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000789	0.00212	CcSEcCtD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—JUN—psoriasis	0.000787	0.00429	CbGpPWpGaD
Tetrahydrobiopterin—Mediastinal disorder—Cyclosporine—psoriasis	0.000786	0.00211	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	0.000782	0.00427	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Calcitriol—psoriasis	0.000777	0.00209	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—CYP2S1—psoriasis	0.000773	0.00422	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Acitretin—psoriasis	0.00077	0.00207	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Fluocinolone Acetonide—psoriasis	0.000768	0.00206	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Mycophenolate mofetil—psoriasis	0.000766	0.00206	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—JUN—psoriasis	0.000763	0.00416	CbGpPWpGaD
Tetrahydrobiopterin—Infection—Mycophenolic acid—psoriasis	0.000761	0.00204	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Cyclosporine—psoriasis	0.000759	0.00204	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000758	0.00413	CbGpPWpGaD
Tetrahydrobiopterin—Nervous system disorder—Mycophenolic acid—psoriasis	0.000751	0.00202	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—psoriasis	0.000746	0.00407	CbGpPWpGaD
Tetrahydrobiopterin—Skin disorder—Mycophenolic acid—psoriasis	0.000744	0.002	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Mycophenolate mofetil—psoriasis	0.00074	0.00199	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Acitretin—psoriasis	0.00074	0.00199	CcSEcCtD
Tetrahydrobiopterin—NOS3—SHP2 signaling—VEGFA—psoriasis	0.00074	0.00403	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—S1P1 pathway—VEGFA—psoriasis	0.000739	0.00403	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Fluocinolone Acetonide—psoriasis	0.000738	0.00198	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—NFKB1—psoriasis	0.000735	0.00401	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Acitretin—psoriasis	0.000734	0.00197	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Acitretin—psoriasis	0.000733	0.00197	CcSEcCtD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—psoriasis	0.000733	0.004	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Fluocinolone Acetonide—psoriasis	0.000732	0.00197	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—LEP—psoriasis	0.000731	0.00399	CbGpPWpGaD
Tetrahydrobiopterin—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000731	0.00196	CcSEcCtD
Tetrahydrobiopterin—Headache—Acitretin—psoriasis	0.000729	0.00196	CcSEcCtD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—IL6—psoriasis	0.000728	0.00397	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Fluocinolone Acetonide—psoriasis	0.000727	0.00195	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Betamethasone—psoriasis	0.000727	0.00195	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Dexamethasone—psoriasis	0.000727	0.00195	CcSEcCtD
Tetrahydrobiopterin—PTGS2—skin of body—psoriasis	0.000725	0.0348	CbGeAlD
Tetrahydrobiopterin—Pharyngitis—Triamcinolone—psoriasis	0.000724	0.00194	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Dexamethasone—psoriasis	0.000723	0.00194	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Betamethasone—psoriasis	0.000723	0.00194	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Hydroxyurea—psoriasis	0.000723	0.00194	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—TNF—psoriasis	0.000722	0.00394	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—NDUFA5—psoriasis	0.000714	0.0039	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriasis	0.000714	0.00389	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—JUN—psoriasis	0.000705	0.00384	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.000697	0.00187	CcSEcCtD
Tetrahydrobiopterin—Agitation—Cyclosporine—psoriasis	0.000697	0.00187	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—psoriasis	0.000697	0.0038	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—TP53—psoriasis	0.000694	0.00378	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Acitretin—psoriasis	0.000692	0.00186	CcSEcCtD
Tetrahydrobiopterin—Nausea—Fluocinolone Acetonide—psoriasis	0.00069	0.00185	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—NOS2—psoriasis	0.000682	0.00372	CbGpPWpGaD
Tetrahydrobiopterin—Agitation—Mycophenolate mofetil—psoriasis	0.00068	0.00183	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000678	0.0037	CbGpPWpGaD
Tetrahydrobiopterin—Malnutrition—Hydrocortisone—psoriasis	0.000674	0.00181	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Mycophenolic acid—psoriasis	0.000674	0.00181	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Hydroxyurea—psoriasis	0.000673	0.00181	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Prednisone—psoriasis	0.000673	0.00181	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—PCNA—psoriasis	0.000668	0.00365	CbGpPWpGaD
Tetrahydrobiopterin—Irritability—Methotrexate—psoriasis	0.000665	0.00179	CcSEcCtD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—NFKB1—psoriasis	0.000663	0.00362	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Cyclosporine—psoriasis	0.000662	0.00178	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000661	0.00178	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—STAT3—psoriasis	0.00066	0.0036	CbGpPWpGaD
Tetrahydrobiopterin—Convulsion—Cyclosporine—psoriasis	0.000657	0.00177	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—psoriasis	0.000651	0.00355	CbGpPWpGaD
Tetrahydrobiopterin—Arthralgia—Cyclosporine—psoriasis	0.000646	0.00174	CcSEcCtD
Tetrahydrobiopterin—Cough—Mycophenolate mofetil—psoriasis	0.000646	0.00173	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000642	0.00172	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Mycophenolate mofetil—psoriasis	0.000641	0.00172	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—TYK2—psoriasis	0.000641	0.0035	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—PPARG—psoriasis	0.000637	0.00348	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—IL6—psoriasis	0.000635	0.00346	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Overview of nanoparticle effects—TNF—psoriasis	0.000633	0.00345	CbGpPWpGaD
Tetrahydrobiopterin—Acute coronary syndrome—Prednisone—psoriasis	0.000633	0.0017	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Mycophenolate mofetil—psoriasis	0.00063	0.00169	CcSEcCtD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—CXCL8—psoriasis	0.00063	0.00343	CbGpPWpGaD
Tetrahydrobiopterin—Myocardial infarction—Prednisone—psoriasis	0.000629	0.00169	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000626	0.00168	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000626	0.00168	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Hydroxyurea—psoriasis	0.000625	0.00168	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Cyclosporine—psoriasis	0.000619	0.00166	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.000616	0.00336	CbGpPWpGaD
Tetrahydrobiopterin—Infection—Cyclosporine—psoriasis	0.000615	0.00165	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Cyclosporine—psoriasis	0.000607	0.00163	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—CYP2S1—psoriasis	0.000607	0.00331	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Mycophenolic acid—psoriasis	0.000605	0.00163	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Mycophenolic acid—psoriasis	0.000605	0.00163	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—TYK2—psoriasis	0.000605	0.0033	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Hydroxyurea—psoriasis	0.000604	0.00162	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000604	0.00162	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—psoriasis	0.000603	0.00329	CbGpPWpGaD
Tetrahydrobiopterin—Skin disorder—Cyclosporine—psoriasis	0.000602	0.00162	CcSEcCtD
Tetrahydrobiopterin—Infection—Mycophenolate mofetil—psoriasis	0.0006	0.00161	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Prednisolone—psoriasis	0.000598	0.00161	CcSEcCtD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—STAT3—psoriasis	0.000596	0.00325	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000595	0.00325	CbGpPWpGaD
Tetrahydrobiopterin—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000592	0.00159	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000588	0.00321	CbGpPWpGaD
Tetrahydrobiopterin—Skin disorder—Mycophenolate mofetil—psoriasis	0.000587	0.00158	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Hydrocortisone—psoriasis	0.000584	0.00157	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—IL6—psoriasis	0.000582	0.00318	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Hydroxyurea—psoriasis	0.000581	0.00156	CcSEcCtD
Tetrahydrobiopterin—Rash—Hydroxyurea—psoriasis	0.000576	0.00155	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Hydroxyurea—psoriasis	0.000576	0.00155	CcSEcCtD
Tetrahydrobiopterin—Headache—Hydroxyurea—psoriasis	0.000573	0.00154	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.00057	0.00153	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000564	0.00152	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Prednisolone—psoriasis	0.000564	0.00151	CcSEcCtD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—NFKB1—psoriasis	0.000563	0.00307	CbGpPWpGaD
Tetrahydrobiopterin—Neutropenia—Methotrexate—psoriasis	0.000563	0.00151	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Methotrexate—psoriasis	0.000559	0.0015	CcSEcCtD
Tetrahydrobiopterin—Cough—Triamcinolone—psoriasis	0.000554	0.00149	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—JUN—psoriasis	0.000553	0.00302	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—tendon—psoriasis	0.000552	0.0265	CbGeAlD
Tetrahydrobiopterin—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.00055	0.00148	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Hydrocortisone—psoriasis	0.00055	0.00148	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Triamcinolone—psoriasis	0.00055	0.00148	CcSEcCtD
Tetrahydrobiopterin—NOS3—Hemostasis—ITGAL—psoriasis	0.00055	0.003	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—psoriasis	0.00055	0.003	CbGpPWpGaD
Tetrahydrobiopterin—Infection—Hydrocortisone—psoriasis	0.000547	0.00147	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Cyclosporine—psoriasis	0.000545	0.00146	CcSEcCtD
Tetrahydrobiopterin—Nausea—Hydroxyurea—psoriasis	0.000543	0.00146	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Hydrocortisone—psoriasis	0.00054	0.00145	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Methotrexate—psoriasis	0.000537	0.00144	CcSEcCtD
Tetrahydrobiopterin—Infestation—Methotrexate—psoriasis	0.000537	0.00144	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000535	0.00144	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Hydrocortisone—psoriasis	0.000535	0.00144	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000533	0.00291	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000532	0.00143	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—TNF—psoriasis	0.000528	0.00288	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Mycophenolic acid—psoriasis	0.000524	0.00141	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000522	0.0014	CcSEcCtD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—TP53—psoriasis	0.000519	0.00283	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	0.000519	0.00283	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Triamcinolone—psoriasis	0.000518	0.00139	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—CAT—psoriasis	0.000517	0.00282	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—CARM1—psoriasis	0.000516	0.00282	CbGpPWpGaD
Tetrahydrobiopterin—Infection—Triamcinolone—psoriasis	0.000515	0.00138	CcSEcCtD
Tetrahydrobiopterin—NOS3—SHP2 signaling—IL6—psoriasis	0.000512	0.00279	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Overview of nanoparticle effects—IL6—psoriasis	0.000511	0.00279	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Fluticasone Propionate—Betamethasone—psoriasis	0.000507	0.0346	CbGdCrCtD
Tetrahydrobiopterin—PTGS2—Fluticasone Propionate—Dexamethasone—psoriasis	0.000507	0.0346	CbGdCrCtD
Tetrahydrobiopterin—Gastrointestinal pain—Cyclosporine—psoriasis	0.000506	0.00136	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Mycophenolic acid—psoriasis	0.000506	0.00136	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Prednisone—psoriasis	0.000502	0.00135	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000501	0.00135	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Betamethasone—psoriasis	0.000499	0.00134	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Dexamethasone—psoriasis	0.000499	0.00134	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	0.000495	0.0338	CbGdCrCtD
Tetrahydrobiopterin—NOS3—Metabolism—NDUFA5—psoriasis	0.000495	0.0027	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000494	0.00133	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Cyclosporine—psoriasis	0.00049	0.00131	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Cyclosporine—psoriasis	0.00049	0.00131	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Mycophenolic acid—psoriasis	0.000487	0.00131	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Hydrocortisone—psoriasis	0.000485	0.0013	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.000484	0.00264	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Mycophenolic acid—psoriasis	0.000483	0.0013	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Mycophenolic acid—psoriasis	0.000482	0.0013	CcSEcCtD
Tetrahydrobiopterin—Headache—Mycophenolic acid—psoriasis	0.00048	0.00129	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Methotrexate—psoriasis	0.000478	0.00128	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000478	0.00128	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000478	0.00128	CcSEcCtD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—IL6—psoriasis	0.000475	0.00259	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000475	0.00128	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000472	0.00127	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Betamethasone—psoriasis	0.00047	0.00126	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Dexamethasone—psoriasis	0.00047	0.00126	CcSEcCtD
Tetrahydrobiopterin—Infection—Dexamethasone—psoriasis	0.000467	0.00125	CcSEcCtD
Tetrahydrobiopterin—Infection—Betamethasone—psoriasis	0.000467	0.00125	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Betamethasone—psoriasis	0.000461	0.00124	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Dexamethasone—psoriasis	0.000461	0.00124	CcSEcCtD
Tetrahydrobiopterin—Agitation—Prednisone—psoriasis	0.000461	0.00124	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Cyclosporine—psoriasis	0.000456	0.00123	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Triamcinolone—psoriasis	0.000456	0.00123	CcSEcCtD
Tetrahydrobiopterin—Nausea—Mycophenolic acid—psoriasis	0.000455	0.00122	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—VEGFA—psoriasis	0.000453	0.00247	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—JUN—psoriasis	0.000452	0.00247	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—psoriasis	0.000451	0.00246	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Hydrocortisone—psoriasis	0.00045	0.00121	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000445	0.0012	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Hydrocortisone—psoriasis	0.000435	0.00117	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Hydrocortisone—psoriasis	0.000435	0.00117	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Prednisone—psoriasis	0.000435	0.00117	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Methotrexate—psoriasis	0.000434	0.00117	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000428	0.00115	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000428	0.00115	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—VEGFA—psoriasis	0.000428	0.00233	CbGpPWpGaD
Tetrahydrobiopterin—Arthralgia—Prednisone—psoriasis	0.000427	0.00115	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—IL6—psoriasis	0.000426	0.00232	CbGpPWpGaD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000424	0.00114	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Cyclosporine—psoriasis	0.000424	0.00114	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—CYP2S1—psoriasis	0.000421	0.0023	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—psoriasis	0.000419	0.00229	CbGpPWpGaD
Tetrahydrobiopterin—Malnutrition—Methotrexate—psoriasis	0.000419	0.00113	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Prednisolone—psoriasis	0.000415	0.00112	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—TNF—psoriasis	0.000414	0.00226	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Dexamethasone—psoriasis	0.000414	0.00111	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Betamethasone—psoriasis	0.000414	0.00111	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000413	0.00111	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—CRP—psoriasis	0.00041	0.00224	CbGpPWpGaD
Tetrahydrobiopterin—Body temperature increased—Triamcinolone—psoriasis	0.00041	0.0011	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Cyclosporine—psoriasis	0.00041	0.0011	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Prednisone—psoriasis	0.00041	0.0011	CcSEcCtD
Tetrahydrobiopterin—Infection—Prednisone—psoriasis	0.000407	0.00109	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Betamethasone—psoriasis	0.000406	0.00109	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000406	0.00109	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Hydrocortisone—psoriasis	0.000406	0.00109	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Prednisone—psoriasis	0.000402	0.00108	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.000401	0.00219	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Mycophenolate mofetil—psoriasis	0.0004	0.00107	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Prednisone—psoriasis	0.000398	0.00107	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Cyclosporine—psoriasis	0.000394	0.00106	CcSEcCtD
Tetrahydrobiopterin—Rash—Cyclosporine—psoriasis	0.00039	0.00105	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Cyclosporine—psoriasis	0.00039	0.00105	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—psoriasis	0.00039	0.00213	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HCAR2—psoriasis	0.000389	0.00212	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Cyclosporine—psoriasis	0.000388	0.00104	CcSEcCtD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—JUN—psoriasis	0.000386	0.0021	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Dexamethasone—psoriasis	0.000385	0.00103	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Betamethasone—psoriasis	0.000385	0.00103	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Mycophenolate mofetil—psoriasis	0.000384	0.00103	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Triamcinolone—psoriasis	0.000382	0.00103	CcSEcCtD
Tetrahydrobiopterin—Rash—Mycophenolate mofetil—psoriasis	0.000381	0.00102	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Mycophenolate mofetil—psoriasis	0.000381	0.00102	CcSEcCtD
Tetrahydrobiopterin—Headache—Mycophenolate mofetil—psoriasis	0.000378	0.00102	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—CARM1—psoriasis	0.000377	0.00206	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—ICAM1—psoriasis	0.000377	0.00206	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Hydrocortisone—psoriasis	0.000377	0.00101	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL4—psoriasis	0.000375	0.00205	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Prednisone—psoriasis	0.000373	0.001	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Prednisolone—psoriasis	0.000373	0.001	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—JUN—psoriasis	0.000372	0.00203	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Dexamethasone—psoriasis	0.000372	0.000998	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Betamethasone—psoriasis	0.000372	0.000998	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Dexamethasone—psoriasis	0.000372	0.000998	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Betamethasone—psoriasis	0.000372	0.000998	CcSEcCtD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—NFKB1—psoriasis	0.000371	0.00202	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Cyclosporine—psoriasis	0.000368	0.000988	CcSEcCtD
Tetrahydrobiopterin—Cough—Methotrexate—psoriasis	0.000366	0.000983	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.000364	0.00199	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Hydrocortisone—psoriasis	0.000364	0.000978	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Methotrexate—psoriasis	0.000363	0.000976	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Prednisone—psoriasis	0.00036	0.000968	CcSEcCtD
Tetrahydrobiopterin—Nausea—Mycophenolate mofetil—psoriasis	0.000359	0.000964	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Methotrexate—psoriasis	0.000357	0.000959	CcSEcCtD
Tetrahydrobiopterin—Rash—Prednisolone—psoriasis	0.000355	0.000954	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Prednisolone—psoriasis	0.000355	0.000953	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000355	0.000952	CcSEcCtD
Tetrahydrobiopterin—Headache—Prednisolone—psoriasis	0.000353	0.000948	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Hydrocortisone—psoriasis	0.00035	0.00094	CcSEcCtD
Tetrahydrobiopterin—Rash—Hydrocortisone—psoriasis	0.000347	0.000932	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Hydrocortisone—psoriasis	0.000347	0.000931	CcSEcCtD
Tetrahydrobiopterin—Headache—Hydrocortisone—psoriasis	0.000345	0.000926	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Triamcinolone—psoriasis	0.000343	0.00092	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	0.000342	0.00187	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Methotrexate—psoriasis	0.000342	0.000919	CcSEcCtD
Tetrahydrobiopterin—Infection—Methotrexate—psoriasis	0.00034	0.000913	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TAGAP—psoriasis	0.000337	0.00184	CbGpPWpGaD
Tetrahydrobiopterin—Nervous system disorder—Methotrexate—psoriasis	0.000336	0.000901	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Prednisone—psoriasis	0.000335	0.000899	CcSEcCtD
Tetrahydrobiopterin—Nausea—Prednisolone—psoriasis	0.000335	0.000899	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—IL6—psoriasis	0.000334	0.00182	CbGpPWpGaD
Tetrahydrobiopterin—Skin disorder—Methotrexate—psoriasis	0.000332	0.000893	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Triamcinolone—psoriasis	0.00033	0.000885	CcSEcCtD
Tetrahydrobiopterin—Nausea—Hydrocortisone—psoriasis	0.000327	0.000878	CcSEcCtD
Tetrahydrobiopterin—Rash—Triamcinolone—psoriasis	0.000327	0.000878	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Triamcinolone—psoriasis	0.000326	0.000877	CcSEcCtD
Tetrahydrobiopterin—Headache—Triamcinolone—psoriasis	0.000325	0.000872	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Prednisone—psoriasis	0.000324	0.000869	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Prednisone—psoriasis	0.000324	0.000869	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—STAT3—psoriasis	0.000322	0.00176	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Dexamethasone—psoriasis	0.000322	0.000864	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Betamethasone—psoriasis	0.000322	0.000864	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—CAT—psoriasis	0.000318	0.00173	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—LEP—psoriasis	0.000317	0.00173	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—IL6—psoriasis	0.000313	0.00171	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—TNF—psoriasis	0.000312	0.0017	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000312	0.000837	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Dexamethasone—psoriasis	0.000311	0.000835	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Betamethasone—psoriasis	0.000311	0.000835	CcSEcCtD
Tetrahydrobiopterin—Nausea—Triamcinolone—psoriasis	0.000308	0.000827	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Prednisone—psoriasis	0.000302	0.00081	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Methotrexate—psoriasis	0.000301	0.000809	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Dexamethasone—psoriasis	0.000299	0.000803	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Betamethasone—psoriasis	0.000299	0.000803	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—TP53—psoriasis	0.000298	0.00163	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—ICAM1—psoriasis	0.000298	0.00163	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Dexamethasone—psoriasis	0.000297	0.000796	CcSEcCtD
Tetrahydrobiopterin—Rash—Betamethasone—psoriasis	0.000297	0.000796	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—CARM1—psoriasis	0.000296	0.00162	CbGpPWpGaD
Tetrahydrobiopterin—Dermatitis—Dexamethasone—psoriasis	0.000296	0.000796	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Betamethasone—psoriasis	0.000296	0.000796	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—NOS2—psoriasis	0.000296	0.00161	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—IL6—psoriasis	0.000296	0.00161	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Methotrexate—psoriasis	0.000295	0.000794	CcSEcCtD
Tetrahydrobiopterin—Headache—Dexamethasone—psoriasis	0.000295	0.000791	CcSEcCtD
Tetrahydrobiopterin—Headache—Betamethasone—psoriasis	0.000295	0.000791	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriasis	0.000292	0.00159	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CD4—psoriasis	0.000288	0.00157	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—IFNG—psoriasis	0.000287	0.00157	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Prednisone—psoriasis	0.00028	0.000753	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Methotrexate—psoriasis	0.00028	0.000752	CcSEcCtD
Tetrahydrobiopterin—Nausea—Betamethasone—psoriasis	0.000279	0.00075	CcSEcCtD
Tetrahydrobiopterin—Nausea—Dexamethasone—psoriasis	0.000279	0.00075	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—IL6—psoriasis	0.000273	0.00149	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Prednisone—psoriasis	0.000271	0.000727	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Methotrexate—psoriasis	0.000271	0.000727	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Methotrexate—psoriasis	0.000271	0.000727	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Prednisone—psoriasis	0.00026	0.000699	CcSEcCtD
Tetrahydrobiopterin—Rash—Prednisone—psoriasis	0.000258	0.000694	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Prednisone—psoriasis	0.000258	0.000693	CcSEcCtD
Tetrahydrobiopterin—Headache—Prednisone—psoriasis	0.000257	0.000689	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Methotrexate—psoriasis	0.000252	0.000677	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—APOE—psoriasis	0.000247	0.00135	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Prednisone—psoriasis	0.000243	0.000653	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.00024	0.00131	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—NFKB1—psoriasis	0.000239	0.0013	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Methotrexate—psoriasis	0.000234	0.000629	CcSEcCtD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—psoriasis	0.000233	0.00127	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—CAT—psoriasis	0.000232	0.00127	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—HLA-A—psoriasis	0.000231	0.00126	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IFNG—psoriasis	0.000227	0.00124	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Methotrexate—psoriasis	0.000226	0.000608	CcSEcCtD
Tetrahydrobiopterin—NOS3—Hemostasis—NOS2—psoriasis	0.000226	0.00123	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Methotrexate—psoriasis	0.000218	0.000584	CcSEcCtD
Tetrahydrobiopterin—Rash—Methotrexate—psoriasis	0.000216	0.00058	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Methotrexate—psoriasis	0.000216	0.000579	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—APOE—psoriasis	0.000215	0.00117	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PPARG—psoriasis	0.000215	0.00117	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Methotrexate—psoriasis	0.000214	0.000576	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CXCL8—psoriasis	0.000211	0.00115	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CARM1—psoriasis	0.000206	0.00112	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Methotrexate—psoriasis	0.000203	0.000546	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Metabolism—NDUFA5—psoriasis	0.000202	0.0011	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCL20—psoriasis	0.000202	0.0011	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	0.000201	0.0011	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—NOS2—psoriasis	0.000201	0.00109	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000189	0.00103	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—TNF—psoriasis	0.000186	0.00101	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—CAT—psoriasis	0.000182	0.000995	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—APOE—psoriasis	0.00018	0.000984	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP2S1—psoriasis	0.000172	0.000939	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—TYK2—psoriasis	0.000164	0.000897	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PPARG—psoriasis	0.000157	0.000857	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—IL6—psoriasis	0.00015	0.000818	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CD4—psoriasis	0.000149	0.000811	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TNF—psoriasis	0.000147	0.000801	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—APOE—psoriasis	0.000142	0.000773	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	0.000133	0.000728	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—VEGFA—psoriasis	0.000131	0.000713	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TP53—psoriasis	0.000129	0.000706	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	0.000128	0.000701	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CAT—psoriasis	0.000126	0.00069	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HLA-A—psoriasis	0.000126	0.000685	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PPARG—psoriasis	0.000123	0.000673	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL6—psoriasis	0.000119	0.000647	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—APOE—psoriasis	0.000117	0.00064	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	0.000117	0.000636	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—STAT3—psoriasis	0.000115	0.000628	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SOCS1—psoriasis	0.000111	0.000607	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NOS2—psoriasis	0.000109	0.000596	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	9.99e-05	0.000545	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—psoriasis	9.88e-05	0.000539	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—APOE—psoriasis	9.82e-05	0.000536	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.02e-05	0.000492	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TYK2—psoriasis	8.95e-05	0.000488	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	8.81e-05	0.00048	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PPARG—psoriasis	8.55e-05	0.000467	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CARM1—psoriasis	8.4e-05	0.000458	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—LEP—psoriasis	8.21e-05	0.000448	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APOE—psoriasis	8.21e-05	0.000448	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CD4—psoriasis	8.09e-05	0.000442	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—IL6—psoriasis	8.04e-05	0.000439	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.86e-05	0.000429	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NFKBIA—psoriasis	7.65e-05	0.000417	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TYK2—psoriasis	6.27e-05	0.000342	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—STAT3—psoriasis	6.27e-05	0.000342	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CXCL8—psoriasis	5.46e-05	0.000298	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CAT—psoriasis	5.17e-05	0.000282	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HLA-A—psoriasis	5.14e-05	0.00028	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—JUN—psoriasis	5.07e-05	0.000277	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NFKB1—psoriasis	4.88e-05	0.000266	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APOE—psoriasis	4.8e-05	0.000262	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOS2—psoriasis	4.47e-05	0.000244	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—VEGFA—psoriasis	4.43e-05	0.000242	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—STAT3—psoriasis	4.39e-05	0.000239	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IL6—psoriasis	4.38e-05	0.000239	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—APOE—psoriasis	4.02e-05	0.000219	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TYK2—psoriasis	3.66e-05	0.0002	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPARG—psoriasis	3.5e-05	0.000191	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—psoriasis	3.35e-05	0.000183	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CD4—psoriasis	3.31e-05	0.000181	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL6—psoriasis	3.07e-05	0.000167	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—STAT3—psoriasis	2.56e-05	0.00014	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IL6—psoriasis	1.79e-05	9.77e-05	CbGpPWpGaD
